Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of macitentan in pulmonary arterial hypertension (SERAPHIN extension, China)
CTR20132047Phase 3Completed
- Sponsor
- Thermo Fisher Scientific
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of macitentan in pulmonary arterial hypertension (PAH), sponsored by Thermo Fisher Scientific. Started Dec 2016; status: completed.
02
Drugs
macitentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on CTR20132047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132047.